Using a patient's tumor to form vaccine: Dendritic cell vaccine induces immune responses in patients

A new process for creating a personalized vaccine may become a crucial tool in helping patients with colorectal cancer develop an immune response against their own tumors. This dendritic cell vaccine was used after surgical resection of metastatic tumors to try to prevent the growth of additional metastases.

Read the whole article on Science Daily

More from Science Daily